Reumatoloxía
Hospital Vall d'Hebron
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (26)
2022
-
Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review
Seminars in Arthritis and Rheumatism, Vol. 52
2021
-
Update of the Position Paper of the Spanish Society of Rheumatology on Biosimilar Drugs
Reumatologia Clinica, Vol. 17, Núm. 3, pp. 160-169
2020
-
Influence of MUC5B gene on antisynthetase syndrome
Scientific Reports, Vol. 10, Núm. 1
-
Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment
Reumatologia Clinica, Vol. 16, Núm. 2P1, pp. 71-86
-
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119
2019
-
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135
2018
-
Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients
Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 1, pp. 22-27
-
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: Results from BIOBADASER
Arthritis Research and Therapy, Vol. 20, Núm. 1
2017
-
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts
British Journal of Dermatology, Vol. 176, Núm. 3, pp. 643-649
2014
-
Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus
Arthritis Research and Therapy, Vol. 16, Núm. 3
2012
-
Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: A case-control study
Arthritis Research and Therapy, Vol. 14, Núm. 2
-
Further Evidence of Subphenotype Association with Systemic Lupus Erythematosus Susceptibility Loci: A European Cases Only Study
PLoS ONE, Vol. 7, Núm. 9
2011
-
Association of systemic lupus erythematosus clinical features with european population genetic substructure
PLoS ONE, Vol. 6, Núm. 12
-
Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists
Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 1, pp. 71-80
2009
-
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
BMC Musculoskeletal Disorders, Vol. 10, Núm. 1
-
Learning and reliability of colour Doppler ultrasound in giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 27, Núm. 1 SUPPL. 52
-
Replication of recently identified systemic lupus erythematosus genetic associations: A case-control study
Arthritis Research and Therapy, Vol. 11, Núm. 3
2007
-
All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
Annals of the Rheumatic Diseases, Vol. 66, Núm. 7, pp. 880-885
-
Opposed independent effects and epistasis in the complex association of IRF5 to SLE
Genes and Immunity, Vol. 8, Núm. 5, pp. 429-438
-
Study of DNASE I gene polymorphisms in systemic lupus erythematosus susceptibility [3]
Annals of the Rheumatic Diseases